HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share (HBIO)

CUSIP: 416906105

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
5,297,433
Total 13F shares
31,032,063
Share change
-137,187
Total reported value
$65,474,380
Price per share
$2.11
Number of holders
93
Value change
-$507,785
Number of buys
47
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 416906105?
CUSIP 416906105 identifies HBIO - HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of HBIO - HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F
Company
55%
2,916,176
$7,844,513 30 Sep 2024
13F
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.
13F
Company
52%
2,772,700
$7,458,563 30 Sep 2024
13F
Harvey Partners, LLC
13F
Company
51%
2,715,000
$7,303,350 30 Sep 2024
13F
AMH Equity Ltd
13F
Company
45%
2,388,868
$6,426,055 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
41%
2,154,052
$5,794,399 30 Sep 2024
13F
Granahan Investment Management, LLC
13F
Company
35%
1,865,429
$5,018,004 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
32%
1,715,879
$4,615,814 30 Sep 2024
13F
272 Capital LP
13F
Company
29%
1,535,820
$4,131,356 30 Sep 2024
13F
ROYCE & ASSOCIATES LP
13F
Company
27%
1,451,450
$3,904,401 30 Sep 2024
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
25%
1,335,820
$3,593,356 30 Sep 2024
13F
HEARTLAND ADVISORS INC
13F
Company
23%
1,200,000
$3,228,000 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
17%
912,599
$2,455,161 30 Sep 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
16%
873,614
$2,347,000 30 Sep 2024
13F
Bertrand Loy
3/4/5
Director
class O/S missing
556,208
$2,286,015 21 May 2024
Meros Investment Management, LP
13F
Company
16%
833,589
$2,242,354 30 Sep 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
14%
724,078
$1,947,770 30 Sep 2024
13F
STATE STREET CORP
13F
Company
14%
717,387
$1,929,771 30 Sep 2024
13F
Michael A. Rossi
3/4/5
Chief Financial Officer
class O/S missing
260,540
$1,393,889 29 Dec 2022
Acuitas Investments, LLC
13F
Company
9.3%
491,092
$1,321,037 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
8.5%
452,036
$1,215,976 30 Sep 2024
13F
Thomas W. Loewald
3/4/5
Director
class O/S missing
295,311
$1,213,728 21 May 2024
Alan I. Edrick
3/4/5
Director
class O/S missing
273,911
$1,125,774 21 May 2024
BARD ASSOCIATES INC
13F
Company
5.9%
312,399
$840,354 30 Sep 2024
13F
Kenneth Fletcher Olson
3/4/5
Chief Operating Officer
class O/S missing
155,595
$832,433 29 Dec 2021
Russell Investments Group, Ltd.
13F
Company
5.7%
301,225
$810,294 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
4.5%
239,696
$644,782 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
4.3%
230,077
$618,907 30 Sep 2024
13F
GREENWOOD CAPITAL ASSOCIATES LLC
13F
Company
4.3%
225,866
$607,580 30 Sep 2024
13F
Assenagon Asset Management S.A.
13F
Company
3.8%
202,315
$544,227 30 Sep 2024
13F
Pasadena Private Wealth, LLC
13F
Company
3.7%
198,039
$532,725 30 Sep 2024
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
3.5%
184,500
$496,305 30 Sep 2024
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
3.4%
180,006
$484,216 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
3.3%
175,424
$471,890 30 Sep 2024
13F
STRS OHIO
13F
Company
3.1%
163,000
$438,470 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
3%
160,349
$431,338 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
2.6%
139,999
$376,597 30 Sep 2024
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
2.4%
128,536
$345,762 30 Sep 2024
13F
ClariVest Asset Management LLC
13F
Company
2.2%
114,271
$325,672 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
2.2%
115,994
$312,024 30 Sep 2024
13F
Riverwater Partners LLC
13F
Company
2%
103,414
$264,740 30 Sep 2024
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
1.8%
94,768
$254,926 30 Sep 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
1.4%
74,676
$200,878 30 Sep 2024
13F
GABELLI FUNDS LLC
13F
Company
1.1%
60,000
$161,400 30 Sep 2024
13F
BARCLAYS PLC
13F
Company
1.1%
58,655
$157,782 30 Sep 2024
13F
WINTON GROUP Ltd
13F
Company
1%
54,559
$146,764 30 Sep 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.75%
39,956
$107,482 30 Sep 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.73%
38,727
$104,169 30 Sep 2024
13F
Legato Capital Management LLC
13F
Company
0.69%
36,425
$97,984 30 Sep 2024
13F
Verition Fund Management LLC
13F
Company
0.64%
34,015
$91,500 30 Sep 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.64%
33,706
$90,669 30 Sep 2024
13F

Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share (HBIO) as of Q4 2024

As of 31 Dec 2024, HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share (HBIO) was held by 93 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,032,063 shares. The largest 10 holders included BlackRock, Inc., PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., Harvey Partners, LLC, AMH Equity Ltd, VANGUARD GROUP INC, ROYCE & ASSOCIATES LP, DIMENSIONAL FUND ADVISORS LP, Granahan Investment Management, LLC, 272 Capital LP, and HEARTLAND ADVISORS INC. This page lists 93 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
93
Q4 2024 holders
93
Holder diff
0
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .